After Alemtuzumab Induction, Tac plus MMF Is Superior to CsA plus MMF in Pediatric Kidney Transplantation.

被引：0
|
作者：
Kaabak, M. [1 ]
Babenko, N. [1 ]
Zokoyev, A. [1 ]
Shapiro, R. [2 ]
机构：
[1] Boris Petrovsky SCS, Moscow, Russia
[2] Mt Sinai Hosp, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C40
引用
收藏
页码：614 / 614
页数：1
相关论文
共 50 条
  • [1] After alemtuzumab induction, Tac plus MMF is superior to CsA plus MMF in pediatric kidney transplantation
    Kaabak, Michael
    Babenko, Nadeen
    Zokoyev, Allan
    Shapiro, Ron
    TRANSPLANTATION, 2016, 100 (07) : S700 - S700
  • [2] Results of MMF plus EVO combination in drug switching after kidney transplantation.
    Ok, Ebru Sevinc
    Toz, Huseyin
    Ozgu, Isik Hasan
    Saracoglu, Ugur
    Ekin, Gokhan
    TRANSPLANTATION, 2024, 108 (09) : 169 - 169
  • [3] Results of MMF plus EVO combination in drug switching after kidney transplantation.
    Ok, Ebru Sevinc
    Toz, Huseyin
    Ozgu, Isik Hasan
    Saracoglu, Ugur
    Ekin, Gokhan
    TRANSPLANTATION, 2024, 108 (9S)
  • [4] Anaemia after conversion from CsA to MMF one year after kidney transplantation.
    van Besouw, NM
    van der Mast, BJ
    Gregoor, PJHS
    Ijzermans, JNM
    van Gelder, T
    Weimar, W
    TRANSPLANTATION, 1999, 67 (07) : S157 - S157
  • [5] Conversion From TAC-MMF To TAC-mTOR Immunosuppression After Kidney-Pancreas Transplantation.
    Knight, R.
    DeVos, J.
    Patel, S.
    Gaber, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 856 - 857
  • [6] Randomized trial of prograf plus MMF or azathioprine versus neural plus MMF after cadaveric kidney transplantation: Results at three years.
    Johnson, C
    Gonwa, T
    Light, J
    Hardy, M
    Ahsan, N
    Metzger, R
    Danovitch, G
    Corwin, C
    Halloran, P
    Wachs, M
    Alfrey, E
    Rocher, L
    Stegall, M
    Shields, C
    Mulloy, L
    Sorensen, J
    Scandling, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 3A - 3A
  • [7] CsA plus MTX plus MMF plus low-dose ATG protocal for GVHD prophylaxis in unrelated donor hematopoietic stem cell transplantation.
    Liu, QF
    Sun, J
    Zhang, Y
    Liu, XL
    Xu, D
    BLOOD, 2003, 102 (11) : 473B - 473B
  • [8] Alemtuzumab Induction with Tacrolimus Monotherapy vs TAC plus MMF Bitherapy in Pancreas Transplant Recipients: 10 Year Experience.
    Tan, H.
    Shapiro, R.
    Tevar, A.
    Donaldson, J.
    Basu, A.
    Sturdevant, M.
    Lopez, R.
    Wijkstrom, M.
    McCauley, J.
    Wu, C.
    Shah, N.
    Humar, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 441 - 441
  • [9] Comparison of Tacrolimus vs MMF Reduction After Kidney Transplantation.
    Salas, M. Posadas
    Nwadike, E.
    Taber, D.
    Pilch, N.
    Salazar, M.
    Srinivas, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 544 - 544
  • [10] Comparison of Tacrolimus vs MMF Reduction After Kidney Transplantation.
    Salas, M. Posadas
    Nwadike, E.
    Taber, D.
    Pilch, N.
    Salazar, M.
    Srinivas, T.
    TRANSPLANTATION, 2014, 98 : 544 - 544
12345